Status
Conditions
Treatments
About
Evaluate the interest of gadolinium for the positive and topographic diagnosis of intra-labyrinthine schwannoma, comparing T1 sequence acquired after gadolinium injection to a sequence of fast imaging type employing steady state acquisition (FIESTA-C)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Francis VEILLON, MD, PhD; Aïna VENKATASAMY, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal